Link found between chronic inflammation and risk for Alzheimer's disease

by Boston University School of MedicineWhile it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD.

Updated on: March 07,2024

Link found between chronic inflammation and risk for Alzheimer's disease

by Boston University School of MedicineWhile it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD.

Updated on:March 07,2024

Nerve cells in the brain can halt all movement in the body—even breathing

JULY 29, 2023byUniversity of CopenhagenBrainstem projection targets from Chx10-PPN neurons. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41593-023-01396-3When a hunting dog picks

Updated on: March 13,2024

Nerve cells in the brain can halt all movement in the body—even breathing

JULY 29, 2023byUniversity of CopenhagenBrainstem projection targets from Chx10-PPN neurons. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41593-023-01396-3When a hunting dog picks

Updated on:March 13,2024

How a common food ingredient can take a wrong turn, leading to arthritis

by Mark Harden,CU Anschutz Medical CampusGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI167671A University of Colorado Department of Medicine fac

Updated on: March 19,2024

How a common food ingredient can take a wrong turn, leading to arthritis

by Mark Harden,CU Anschutz Medical CampusGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI167671A University of Colorado Department of Medicine fac

Updated on:March 19,2024

New Alzheimer trial to use epilepsy drug that calms brain activity

by Scott Dance, The Baltimore SunWhat could be one of the first treatments to delay or prevent Alzheimer's disease received a big boost from the National Institute on Aging, which is putting up $7

Updated on: February 26,2024

New Alzheimer trial to use epilepsy drug that calms brain activity

by Scott Dance, The Baltimore SunWhat could be one of the first treatments to delay or prevent Alzheimer's disease received a big boost from the National Institute on Aging, which is putting up $7

Updated on:February 26,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on: February 03,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on:February 03,2024

Research suggests myelin fatty acid metabolism could serve as an energy reserve for the central nervous system

by Ingrid Fadelli , Medical XpressElectron microscopy image of optic nerve myelin. Credit: Wiebke Moebius, MPI Goettingen.The brains of mammals expend a significant amount of energy in the form of ade

Updated on: October 18,2024

Research suggests myelin fatty acid metabolism could serve as an energy reserve for the central nervous system

by Ingrid Fadelli , Medical XpressElectron microscopy image of optic nerve myelin. Credit: Wiebke Moebius, MPI Goettingen.The brains of mammals expend a significant amount of energy in the form of ade

Updated on:October 18,2024

New Alzheimer's disease pathways identified

by University of LübeckPath model of main findings. This path model summarizes the main-effect mediation model. Circles indicate principal components or latent variables, rectangles represent observed

Updated on: March 02,2024

New Alzheimer's disease pathways identified

by University of LübeckPath model of main findings. This path model summarizes the main-effect mediation model. Circles indicate principal components or latent variables, rectangles represent observed

Updated on:March 02,2024

Genomics- and image-guided subtyping refines characterization of Alzheimer's disease

by Society of Nuclear Medicine and Molecular ImagingRight and left hemisphere brain surface plots showing the strength of the canonical vector, νƙ, for each subtype. Credit: Images created by Fan Yang

Updated on: June 14,2024

Genomics- and image-guided subtyping refines characterization of Alzheimer's disease

by Society of Nuclear Medicine and Molecular ImagingRight and left hemisphere brain surface plots showing the strength of the canonical vector, νƙ, for each subtype. Credit: Images created by Fan Yang

Updated on:June 14,2024

Not every young reader's struggle is the same

by Anne Trafton,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainMany children struggle to learn to read, and studies have shown that students from a lower socioeconomic st

Updated on: February 03,2024

Not every young reader's struggle is the same

by Anne Trafton,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainMany children struggle to learn to read, and studies have shown that students from a lower socioeconomic st

Updated on:February 03,2024

Alzheimer's beginnings prove to be a sticky situation

by Layne Cameron , Lisa Lapidus,Michigan State UniversityMSU's Lisa Lapidus uses lasers to reveal a common trait of Alzheimer's beginnings. Credit: G.L. KohuthLaser technology has reveal

Updated on: April 18,2024

Alzheimer's beginnings prove to be a sticky situation

by Layne Cameron , Lisa Lapidus,Michigan State UniversityMSU's Lisa Lapidus uses lasers to reveal a common trait of Alzheimer's beginnings. Credit: G.L. KohuthLaser technology has reveal

Updated on:April 18,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on: April 18,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on:April 18,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on: April 20,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on:April 20,2024